Literature DB >> 28874092

Anxiety and Fear of Recurrence Despite a Good Prognosis: An Interview Study with Differentiated Thyroid Cancer Patients.

Christel Hedman1,2, Peter Strang2,3, Therese Djärv4, Ida Widberg1,5, Catharina Ihre Lundgren1.   

Abstract

BACKGROUND: Despite a good prognosis, fear of recurrence is prevalent, even several years after a diagnosis of differentiated thyroid cancer (DTC). For this reason, the aim of this study was to make an in-depth exploration of anxiety, sources of anxiety, and protective strategies.
METHODS: In order to capture a broad description of the phenomenon, a purposeful, maximum variation sampling strategy regarding age, sex, stage of disease, educational level, and time since diagnosis was used. In total, 21 patients were included in the study. Semi-structured interviews were tape-recorded, transcribed verbatim, and analyzed with a qualitative content analysis.
RESULTS: Patients with and without recurrences narrated a picture indicating anxiety related to their current situation; future risks and threats were central to this picture. However, they initially minimized or even denied having anxiety, but subsequently described it as a major problem at the end of the interviews. Anxiety was related to risk of recurrence and the risk of developing other cancers, but also to fears of a future situation where no further treatment options were available. Previous experiences of delayed investigations added to these fears. In order to cope, patients developed protective strategies in order to keep evasive and frightening thoughts away. Everyday life, distractions, and focusing on "the small things in life" were examples of such strategies.
CONCLUSIONS: Anxiety is a common, although partially hidden, problem in DTC survivors, as they tended to deny it early in the dialogues. As anxiety is clearly related to follow-up routines, these should therefore be revaluated.

Entities:  

Keywords:  DTC; anxiety; interview; qualitative; quality of life

Mesh:

Year:  2017        PMID: 28874092     DOI: 10.1089/thy.2017.0346

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  17 in total

1.  Prevalence and factors associated with fear of recurrence in a mixed sample of young adults with cancer.

Authors:  Breanna E Lane; Sheila N Garland; Karine Chalifour; Geoff Eaton; Sophie Lebel; Jacqueline Galica; Christine Maheu; Sébastien Simard
Journal:  J Cancer Surviv       Date:  2019-08-29       Impact factor: 4.442

2.  Too Much of a Good Thing? A Cautionary Tale of Thyroid Cancer Overdiagnosis and Overtreatment.

Authors:  Maria Papaleontiou; Megan R Haymart
Journal:  Thyroid       Date:  2020-04-15       Impact factor: 6.568

Review 3.  Patient perception of receiving a thyroid cancer diagnosis.

Authors:  Catherine B Jensen; Susan C Pitt
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-10-01       Impact factor: 3.626

4.  Mental Health in Postoperative Thyroid Patients During the COVID-19 Pandemic.

Authors:  Shijie Yang; Xiequn Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

5.  Patient Report of Recurrent and Persistent Thyroid Cancer.

Authors:  Maria Papaleontiou; Josh M Evron; Nazanene H Esfandiari; David Reyes-Gastelum; Kevin C Ward; Ann S Hamilton; Francis Worden; Megan R Haymart
Journal:  Thyroid       Date:  2020-04-16       Impact factor: 6.568

6.  Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.

Authors:  Hakim-Moulay Dehbi; Ujjal Mallick; Jonathan Wadsley; Kate Newbold; Clive Harmer; Allan Hackshaw
Journal:  Lancet Diabetes Endocrinol       Date:  2018-11-27       Impact factor: 32.069

7.  Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery.

Authors:  Yusaku Yoshida; Kiyomi Horiuchi; Takahiro Okamoto
Journal:  Thyroid       Date:  2020-02-06       Impact factor: 6.568

8.  Physician management of thyroid cancer patients' worry.

Authors:  Maria Papaleontiou; Bradley Zebrack; David Reyes-Gastelum; Andrew J Rosko; Sarah T Hawley; Ann S Hamilton; Kevin C Ward; Megan R Haymart
Journal:  J Cancer Surviv       Date:  2020-09-16       Impact factor: 4.062

9.  Study protocol of the BLANKET trial: a cluster randomised controlled trial on the (cost-) effectiveness of a primary care intervention for fear of cancer recurrence in cancer survivors.

Authors:  Yvonne L Luigjes-Huizer; Marije L van der Lee; Niek J de Wit; Charles W Helsper
Journal:  BMJ Open       Date:  2019-12-02       Impact factor: 2.692

10.  Patients' Reaction to Diagnosis with Thyroid Cancer or an Indeterminate Thyroid Nodule.

Authors:  Susan C Pitt; Megan C Saucke; Elizabeth M Wendt; David F Schneider; Jason Orne; Cameron L Macdonald; Nadine P Connor; Rebecca S Sippel
Journal:  Thyroid       Date:  2020-11-04       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.